Humacyte Share Price

Humacyte Share Price

NASDAQ: HUMA | Micro Cap | Healthcare
$0.49
-$0.01 (-1.79%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Humacyte Stock Performance

Open
$0.52
Prev. Close
$0.50
Circuit Range
N/A
Day Range
$0.49 - $0.52
Year Range
$0.34 - $1.52
Volume
22,642
Average Traded
$0.50

Humacyte Share Price Today

As of 19 November 2026, Humacyte, Inc.'s share price is $0.49. The stock opened at $0.52, compared to its previous close of $0.50. During today's trading session, Humacyte, Inc.'s share price traded between $0.49 and $0.52, with an average price of $0.51. Over the past 52 weeks, the stock has recorded a high of $1.52 and a low of $0.34. In terms of performance, Humacyte, Inc.'s share price has declined by 62.02% over the last six months and is down 63.56% on a year-on-year basis.

Humacyte Share Price Chart

Line chart of the Humacyte price trend over the selected period. The price fell overall, ranging from 0.49 to 0.52, ending at 0.49.
$0.49$0.52
L
Show Current Price
H

Humacyte Stock Fundamentals & Key Indicators

Market Cap
$78.08M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.34
Revenue (TTM)
$2.04B
Return On Equity (TTM)
-524.60%
Profit Margin
-2001.47%
Debt to Equity
3.68
Quarterly Earnings Growth YoY
37.34%

Humacyte Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.47$0.50$0.41$1.03
Net Profit-$24.80-$17.62-$36.80-$15.54
Net Profit Margin-5276.60%-3524.00%-8975.61%-1508.74%
Income ChangeN/A28.95%-108.85%57.77%

Humacyte Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.57$0.00$0.00$2.04
Net Profit-$11.97-$110.78-$148.70-$40.83
Net Profit Margin-762.42%N/AN/A-2001.47%
Income ChangeN/A-825.48%-34.23%72.54%

Humacyte Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets48.5790.0144.9550.09
Current Assets67.847.8683.28154.21
Total Assets116.37137.87128.22204.3
Non Current Liabilities94.89170.5996.2367.79
Current Liabilities18.3719.9518.4419.58
Total Liabilities113.26190.54114.6887.37
Shareholders' Equity3.11-52.6713.55116.93

Humacyte Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-105.04-98.12-83.334.64
Investing-0.88-1.57-0.174.85
Financing61.49114.1814.53-77.21

About Humacyte

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Humacyte Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.42
$0.50
+21.57%
Oct 2026
$0.52
$0.41
-20.78%
Sep 2026
$0.60
$0.52
-25.90%
Aug 2026
$0.66
$0.69
+6.43%
Jul 2026
$0.77
$0.65
-16.50%
Jun 2026
$1.29
$0.78
-39.85%
May 2026
$0.82
$1.30
+54.03%
Apr 2026
$0.62
$0.84
+39.74%
Mar 2026
$1.07
$0.60
-45.59%
Feb 2026
$0.98
$1.11
+11.45%
Jan 2026
$0.98
$1.00
+3.75%
Dec 2025
$1.33
$0.96
-29.15%

Humacyte Share Price FAQs